(WASHINGTON) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second …
FDA Approves Second Alzheimer’s Drug That Can Slow Disease Read More »
A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the risks of the newest experimental drug for Alzheimer’s disease. Alzheimer’s afflicts more than six million Americans. It has no cure, and there is no treatment or lifestyle modification that can restore memory loss or reverse …
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug Read More »
Waltz Health, a digital search engine for prescription pricing and reimbursement, announced its move into the Medicare market. The Chicago-based company will provide health plans supporting Medicare beneficiaries in accessing lower prescription drug prices via its Marketplace Search technology, an AI-enabled search engine that health organizations can give to their consumers that utilizes data from …
Discount drug company Waltz Health moves into Medicare market Read More »
Why It Matters: The price offers kick off negotiations. The medicines selected for negotiations are taken by millions of older Americans to treat conditions like diabetes, cancer and heart failure. The administration identified them in August, beginning a lengthy process intended to result in an agreed-upon price that would take effect in 2026, assuming the …
U.S. Makes Initial Offers in Medicare Drug Price Negotiations Read More »
Indian AI drug discovery firm gets $1M to focus on rare diseases Peptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest. In a statement, the AI-driven drug discovery company said it will use its fresh funds to expand its research scope to cover rare diseases, …
$1M funding for AI drug discovery for rare diseases and more digital health fundings Read More »
For people with schizophrenia, treatment is an ongoing, life-long process of antipsychotic medications and psychotherapy. Medications are key to controlling episodes, but most have serious enough side effects—including uncontrolled muscle movements, gaining weight and drowsiness—that people skip doses or decide not to take them. In a study published Dec. 14 in the Lancet, researchers report …
A New Drug Compound Shows Promise for Schizophrenia Read More »
Each year, the U.S. government spends over $100 billion investing in the research and development of new technologies, with pharmaceutical companies being among the chief beneficiaries of this research. These public-private partnerships have led to some of the most important pharmaceutical developments of our time, including the COVID-19 vaccine. But with that partnership, however, there …
The White House’s Latest Move to Rein in Drug Prices Read More »
Walgreens is collaborating with medication access and transparency technology company RxSense to launch a digital marketplace, Rx Savings Finder, where consumers can save money on medication by comparing prices on free third-party discount prescription cards. RxSense’s SaaS platform allows companies to create a pharmacy benefits platform. The company offers analytics, prescription savings program adjudication, digital …
Walgreens, RxSense partner to give consumers prescription drug discounts Read More »
Popular weight loss drugs have dominated news headlines and social media, mostly for their ability to help people shed pounds and control diabetes. But now there is evidence that one of the drugs, semaglutide, can also help reduce the risk of dying from heart disease in some patients. The drug semaglutide is sold under the …
Weight Loss Drug Wegovy Can Also Reduce Risk of Heart Events Read More »
CVS Caremark, a pharmacy benefit manager and part of CVS Health, announced it is partnering with drug cost and telehealth company GoodRx to launch Caremark Cost Saver, providing Caremark’s members access to GoodRx’s lower-cost prescription pricing. Beginning January 1, 2024, Caremark’s members can use their existing benefit card at an in-network pharmacy of their choice …
CVS Caremark partners with GoodRx to expand low-cost drug access Read More »
Slurrp Farm High Protein Chocolate Swirl Milk Mix | 250g & Slurrp Farm Healthy Breakfast and Snacks Trial Pack Combo, Millet Pancake and Dosa Mix, 300g (Pack of 6, 50g Each)
₹591.00
Nestle LACTOGROW Nutritious Milk Drink (2-6 Years)- 400G Bag-In-Box Pack (Biscuity And Vanilla Flavour Powder) (Pack of 2)
₹718.00
Slurrp Farm High Protein Chocolate Swirl Milk Mix | 250g & Slurrp Farm No Maida Millet Noodles | Not Fried, No MSG | Foxtail Millet and Little Millet Noodles Combo | Pack of 2-192g Each
₹529.00
Slurrp Farm High Protein Chocolate Swirl Milk Mix | No Maida, No Sugar | Contains Goodness of Millets- Made with Ragi and Jowar | 250g & Slurrp Farm Coconut Sugar – Natural Sweetener, 300g
₹568.00
Slurrp Farm High Protein Chocolate Swirl Milk Mix | 250g & Slurrp Farm Healthy Breakfast and Snacks Trial Pack Combo, Millet Pancake and Dosa Mix, 300g (Pack of 6, 50g Each)
₹591.00
Nestle LACTOGROW Nutritious Milk Drink (2-6 Years)- 400G Bag-In-Box Pack (Biscuity And Vanilla Flavour Powder) (Pack of 2)
₹718.00
Slurrp Farm High Protein Chocolate Swirl Milk Mix | 250g & Slurrp Farm No Maida Millet Noodles | Not Fried, No MSG | Foxtail Millet and Little Millet Noodles Combo | Pack of 2-192g Each
₹529.00
Slurrp Farm High Protein Chocolate Swirl Milk Mix | No Maida, No Sugar | Contains Goodness of Millets- Made with Ragi and Jowar | 250g & Slurrp Farm Coconut Sugar – Natural Sweetener, 300g
₹568.00
